CLICK HERE FOR INVESTOR PORTAL
Hadean Ventures
Hadean Ventures
Hadean Ventures
  • HOME
  • TEAM
  • NEWS
  • PORTFOLIO
  • INVESTORS
  • IMPACT
  • EVENTS
  • CAREERS
  • CONTACT

    @hadeanventures

  • All
  • 2017
  • 2018
  • 2019
  • 2020
  • 2021
  • 2022
  • 2023
  • 2024
  • 2025
  • 2026
  • careers
  • Current companies
  • Exited companies
  • News
  • Portfolio
  • Hadean Ventures invest in Galecto`s $64 million round equity financing

    by @hadeanventures on September 25, 2020

    Hadean Ventures invest in Galecto`s $64 million round equity financing — Hadean Ventures Home Portfolio…

    Continue Reading
  • Ingrid Teigland Akay included in Business Insider’s list of 100 People Transforming Business in Europe.

    by @hadeanventures on September 14, 2020

    Ingrid Teigland Akay included in Business Insider’s list of 100 People Transforming Business in Europe.…

    Continue Reading
  • Abliva intends to start a pivotal KL1333 study second half 2021

    by @hadeanventures on September 9, 2020

    Abliva intends to start a pivotal KL1333 study second half 2021 — Hadean Ventures Home…

    Continue Reading
  • Oncoinvent Advances Radspherin[®] to Second Dose Level in Ongoing Phase 1 Clinical Trial

    by @hadeanventures on September 4, 2020

    Oncoinvent Advances Radspherin[®] to Second Dose Level in Ongoing Phase 1 Clinical Trial — Hadean…

    Continue Reading
  • Pewin Member Highlight 2020: Ingrid Teigland Akay

    by @hadeanventures on August 14, 2020

    Pewin Member Highlight 2020: Ingrid Teigland Akay — Hadean Ventures Home Portfolio Team Impact Investors…

    Continue Reading
  • CARDIOMECH

    by @hadeanventures on August 13, 2020

    CardioMech AS is a privately-held Norwegian company that develops an innovative technology...

    Continue Reading
  • GESYNTA PHARMA

    by @hadeanventures on August 10, 2020

    Gesynta Pharma is a privately held Swedish company located in Stockholm...

    Continue Reading
  • CardioMech AS Announces $18.5M Series A for its Transcatheter Mitral Valve Repair Technology

    by @hadeanventures on August 6, 2020

    CardioMech AS Announces $18.5M Series A...

    Continue Reading
  • Gesynta raises SEK 190 million in round led by Hadean Ventures to accelerate development of first-in-class mPGES-1 inhibitor GS-248 for systemic sclerosis

    by @hadeanventures on July 28, 2020

    Gesynta raises SEK 190 million in round led by Hadean Ventures to accelerate development of…

    Continue Reading
  • Pipeline Therapeutics Initiates Phase 1/2a Clinical Trial of PIPE-505 in Sensorineural Hearing Loss

    by @hadeanventures on July 28, 2020

    Pipeline Therapeutics Initiates Phase 1/2a Clinical Trial of PIPE-505 in Sensorineural Hearing Loss — Hadean…

    Continue Reading
  • ←
  • 1
  • 2
  • 3
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • →
  • HOME
  • TEAM
  • NEWS
  • PORTFOLIO
  • INVESTORS
  • IMPACT
  • EVENTS
  • CAREERS
  • CONTACT

What are you looking for?